LakeShore Biopharma (NASDAQ:LSB), formerly YS Biopharma, is a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer. Learn more at www.ysbiopharm.com.
Location: China, Beijing
Employees: 501-1000
Founded date: 2002
Investors 2
| Date | Name | Website |
| 10.06.2023 | F-Prime Ca... | fprimecapi... |
| 22.11.2023 | Adjuvant C... | adjuvantca... |
Mentions in press and media 1
| Date | Title | Description |
| 09.02.2024 | YS Biopharma Announces US$40 Million Private Placement Financing | GAITHERSBURG, Md., Feb. 9, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma") along with its subsidiaries ("YS Group" or the "Company"), a global biopharmaceutical company dedicated to di... |